Literature DB >> 19965526

Adverse safety events in chronic kidney disease: the frequency of "multiple hits".

Erica Chapin1, Min Zhan, Van Doren Hsu, Stephen L Seliger, Loreen D Walker, Jeffrey C Fink.   

Abstract

BACKGROUND AND OBJECTIVES: Chronic kidney disease (CKD) lacks standardized patient safety indicators (PSIs); however, undetected safety events are likely to contribute to adverse outcomes in this disease. This study sought to determine the proportion of CKD patients who experience multiple potentially hazardous events from varied causes and to identify risk factors for the occurrence of "multiple hits." DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A sample of patients with CKD (n = 70,154) in the Veterans Health Administration (VHA) were retrospectively examined for the occurrence of one or more safety events from a set of indicators defined a priori, including Agency for Healthcare Research and Quality (AHRQ) PSIs, hypoglycemia, hyperkalemia, and dosing for selected medications not accounting for CKD.
RESULTS: Approximately half of the cohort participants experienced one or two adverse safety events, whereas 7% had three or four (multiple) distinct events. Individuals with three or four of the predesignated safety events were more likely to be diabetic, non-Caucasian, have an estimated GFR (eGFR) < 30 ml/min/1.73 m(2), and be < or =65 yr of age. A "Safety Risk Index" was developed using these characteristics, and those subjects that had all four traits were 25 times as likely to have three or four adverse safety events versus those with none of the characteristics.
CONCLUSIONS: Patients with CKD are at a high risk for safety events pertinent to this disease and a substantial number are subject to multiple events from a diverse set of safety indicators, which could have important consequences in disease outcomes.

Entities:  

Mesh:

Year:  2009        PMID: 19965526      PMCID: PMC2801657          DOI: 10.2215/CJN.06210909

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  13 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Assessing kidney function--measured and estimated glomerular filtration rate.

Authors:  Lesley A Stevens; Josef Coresh; Tom Greene; Andrew S Levey
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

Review 3.  Making performance indicators work: experiences of US Veterans Health Administration.

Authors:  Eve A Kerr; Barbara Fleming
Journal:  BMJ       Date:  2007-11-10

4.  Using administrative databases for outcomes research: select examples from VA Health Services Research and Development.

Authors:  D C Cowper; D M Hynes; J D Kubal; P A Murphy
Journal:  J Med Syst       Date:  1999-06       Impact factor: 4.460

5.  Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients.

Authors:  Andrea Corsonello; Claudio Pedone; Francesco Corica; Chiara Mussi; Pierugo Carbonin; Raffaele Antonelli Incalzi
Journal:  Arch Intern Med       Date:  2005-04-11

6.  Prevalence of chronic kidney disease in the United States.

Authors:  Josef Coresh; Elizabeth Selvin; Lesley A Stevens; Jane Manzi; John W Kusek; Paul Eggers; Frederick Van Lente; Andrew S Levey
Journal:  JAMA       Date:  2007-11-07       Impact factor: 56.272

Review 7.  The US Agency for Healthcare Research and Quality's activities in patient safety research.

Authors:  Gregg S Meyer; James Battles; James C Hart; Ning Tang
Journal:  Int J Qual Health Care       Date:  2003-12       Impact factor: 2.038

8.  Data resources in the Department of Veterans Affairs.

Authors:  Charles Maynard; Michael K Chapko
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

9.  Chronic kidney disease adversely influences patient safety.

Authors:  Stephen L Seliger; Min Zhan; Van Doren Hsu; Lori D Walker; Jeffrey C Fink
Journal:  J Am Soc Nephrol       Date:  2008-09-05       Impact factor: 10.121

10.  The frequency of hyperkalemia and its significance in chronic kidney disease.

Authors:  Lisa M Einhorn; Min Zhan; Van Doren Hsu; Lori D Walker; Maureen F Moen; Stephen L Seliger; Matthew R Weir; Jeffrey C Fink
Journal:  Arch Intern Med       Date:  2009-06-22
View more
  28 in total

1.  Safety events in kidney transplant recipients: results from the folic Acid for vascular outcome reduction in transplant trial.

Authors:  Matthew R Weir; Lisa Gravens-Muller; Nadiesda Costa; Anastasia Ivanova; Wana Manitpisitkul; Andrew G Bostom; Clarissa J Diamantidis
Journal:  Transplantation       Date:  2015-05       Impact factor: 4.939

Review 2.  Patient and facility safety in hemodialysis: opportunities and strategies to develop a culture of safety.

Authors:  Renee Garrick; Alan Kliger; Beth Stefanchik
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 8.237

3.  Use of a Medical-Alert Accessory in CKD: A Pilot Study.

Authors:  Eli Farhy; Clarissa Jonas Diamantidis; Rebecca M Doerfler; Wanda J Fink; Min Zhan; Jeffrey C Fink
Journal:  Clin J Am Soc Nephrol       Date:  2019-06-06       Impact factor: 8.237

4.  Self-reported Medication Adherence and Adverse Patient Safety Events in CKD.

Authors:  Kailin L Hsu; Jeffrey C Fink; Jennifer S Ginsberg; Marni Yoffe; Min Zhan; Wanda Fink; Corinne M Woods; Clarissa J Diamantidis
Journal:  Am J Kidney Dis       Date:  2015-05-13       Impact factor: 8.860

Review 5.  Development of quality indicators for care of chronic kidney disease in the primary care setting using electronic health data: a RAND-modified Delphi method.

Authors:  Shingo Fukuma; Sayaka Shimizu; Kakuya Niihata; Ken-Ei Sada; Motoko Yanagita; Tsuguru Hatta; Masaomi Nangaku; Ritsuko Katafuchi; Yoshiro Fujita; Junji Koizumi; Shunzo Koizumi; Kenjiro Kimura; Shunichi Fukuhara; Yugo Shibagaki
Journal:  Clin Exp Nephrol       Date:  2016-05-04       Impact factor: 2.801

6.  Consideration of ICD-9 code-derived disease-specific safety indicators in CKD.

Authors:  Iris R Hartley; Jennifer S Ginsberg; Clarissa J Diamantidis; Min Zhan; Loreen Walker; Gail B Rattinger; Jeffrey C Fink
Journal:  Clin J Am Soc Nephrol       Date:  2013-09-19       Impact factor: 8.237

Review 7.  Reducing hospital readmissions in patients with end-stage kidney disease.

Authors:  Anna T Mathew; Giovanni F M Strippoli; Marinella Ruospo; Steven Fishbane
Journal:  Kidney Int       Date:  2015-10-14       Impact factor: 10.612

Review 8.  Chronic Kidney Disease Diagnosis and Management: A Review.

Authors:  Teresa K Chen; Daphne H Knicely; Morgan E Grams
Journal:  JAMA       Date:  2019-10-01       Impact factor: 56.272

9.  Prescription of high-risk medications among patients with chronic kidney disease: a cross-sectional study from the Washington, Wyoming, Alaska, Montana and Idaho region Practice and Research Network.

Authors:  Janelle Guirguis-Blake; Gina A Keppel; John Holmes; Rex W Force; William Kriegsman; Laura-Mae Baldwin
Journal:  Fam Pract       Date:  2018-09-18       Impact factor: 2.267

10.  Patient-reported and actionable safety events in CKD.

Authors:  Jennifer S Ginsberg; Min Zhan; Clarissa J Diamantidis; Corinne Woods; Jingjing Chen; Jeffrey C Fink
Journal:  J Am Soc Nephrol       Date:  2014-02-20       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.